Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening.
Ibrahim El-BattrawyHuan LanLukas CyganekLasse MaywaldRujia ZhongFeng ZhangQiang XuJihyun LeeEliane DuperrexAndreas HierlemannArdan M SagunerFirat DuruBoldizsar KovacsMengying HuangZhenxing LiaoSebastian AlbersJonas MüllerHendrik DinkelLena RoseAlyssa HohnZhen YangLin QiaoYingrui LiSiegfried LangMandy KleinsorgeAndreas MüggeAssem AweimerXuehui FanSebastian DieckeIbrahim AkinGuang LiXiaobo ZhouPublished in: Clinical and translational medicine (2022)